Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-04 6:11 pm |
aTYR PHARMA INC | ATYR | DENYES NANCY General Counsel |
899 | $3.78 | $3,398 | 29,242 (Direct) |
View |
| 2024-06-05 Purchase |
2024-06-06 08:26 am |
aTYR PHARMA INC | ATYR | DENYES NANCY General Counsel |
5,000 | $1.8552 | $9,276 | 22,267 (Direct) |
View |
| 2020-05-20 Sale |
2020-05-28 8:26 pm |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
322 | $3.62 | $1,166 | 32,735 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-03 Exercise |
2025-02-04 6:11 pm |
N/A N/A |
aTYR PHARMA INC | ATYR | DENYES NANCY General Counsel |
2,687 | $0 | 29,242 (Direct) |
View |
| 2025-01-08 Option Award |
2025-01-10 4:01 pm |
N/A 2035-01-08 |
aTYR PHARMA INC | ATYR | DENYES NANCY General Counsel |
275,000 | $0 | 275,000 (Direct) |
View |
| 2024-02-05 Exercise |
2024-02-06 8:15 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
2,688 | $0 | 20,141 (Direct) |
View |
| 2024-01-05 Option Award |
2024-01-09 7:30 pm |
N/A 2034-01-05 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
150,000 | $0 | 162,079 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 5:00 pm |
N/A 2033-02-16 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
84,023 | $0 | 84,023 (Direct) |
View |
| 2023-02-03 Exercise |
2023-02-06 7:03 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
2,688 | $0 | 15,141 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:34 pm |
N/A 2032-05-24 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
88,097 | $0 | 91,544 (Direct) |
View |
| 2022-02-03 Option Award |
2022-02-07 4:59 pm |
N/A 2032-02-03 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
32,250 | $0 | 32,250 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-25 9:06 pm |
N/A 2025-05-21 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
59,000 | $0 | 62,091 (Direct) |
View |
| 2021-02-04 Option Award |
2021-02-08 8:13 pm |
N/A 2031-02-04 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
45,000 | $0 | 45,000 (Direct) |
View |
| 2020-05-26 Option Award |
2020-05-28 8:26 pm |
N/A 2030-05-26 |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
30,000 | $0 | 32,735 (Direct) |
View |
| 2020-05-16 Exercise |
2020-05-28 8:26 pm |
N/A N/A |
aTYR PHARMA INC | LIFE | DENYES NANCY General Counsel |
892 | $0 | 32,735 (Direct) |
View |